Zustand: very_good. This books is in Very good condition. There may be a few flaws like shelf wear and some light wear.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 115,66
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 115,66
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Zustand: New. pp. 254.
Zustand: New. Editor(s): Torbett, Bruce; Goodsell, David S.; Richman, Douglas D. Series: Current Topics in Microbiology and Immunology. Num Pages: 264 pages, biography. BIC Classification: MJCJ; MMFM; MMG. Category: (G) General (US: Trade). Dimension: 235 x 155 x 16. Weight in Grams: 561. . 2015. Hardback. . . . .
Zustand: New. pp. 254.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 156,94
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 2015 edition. 266 pages. 9.25x6.25x0.75 inches. In Stock.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. The Future of HIV-1 Therapeutics | Resistance Is Futile? | Bruce E. Torbett (u. a.) | Taschenbuch | Current Topics in Microbiology and Immunology | x | Englisch | 2016 | Springer | EAN 9783319374505 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Zustand: New. Editor(s): Torbett, Bruce; Goodsell, David S.; Richman, Douglas D. Series: Current Topics in Microbiology and Immunology. Num Pages: 264 pages, biography. BIC Classification: MJCJ; MMFM; MMG. Category: (G) General (US: Trade). Dimension: 235 x 155 x 16. Weight in Grams: 561. . 2015. Hardback. . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Springer International Publishing, 2016
ISBN 10: 3319374508 ISBN 13: 9783319374505
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.
Sprache: Englisch
Verlag: Springer International Publishing, Springer International Publishing, 2015
ISBN 10: 3319185179 ISBN 13: 9783319185170
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 154,91
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. reprint edition. 264 pages. 9.25x6.10x0.60 inches. In Stock.
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 264 | Sprache: Englisch | Produktart: Bücher | This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 193,40
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Like New. Like New. book.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 86,24
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 86,24
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Sprache: Englisch
Verlag: Springer International Publishing Okt 2016, 2016
ISBN 10: 3319374508 ISBN 13: 9783319374505
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike. 264 pp. Englisch.
Sprache: Englisch
Verlag: Springer International Publishing Mai 2015, 2015
ISBN 10: 3319185179 ISBN 13: 9783319185170
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike. 264 pp. Englisch.
Sprache: Englisch
Verlag: Springer International Publishing, 2016
ISBN 10: 3319374508 ISBN 13: 9783319374505
Anbieter: moluna, Greven, Deutschland
EUR 92,27
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Highlights the identification and evaluation of antiretrovirals that may be less prone in selecting for HIV-1 resistanceCovers recent advances in the identification and function of small molecule inhibitors that target novel HIV-1 regulatory and s.
Sprache: Englisch
Verlag: Springer International Publishing, 2015
ISBN 10: 3319185179 ISBN 13: 9783319185170
Anbieter: moluna, Greven, Deutschland
EUR 92,27
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Highlights the identification and evaluation of antiretrovirals that may be less prone in selecting for HIV-1 resistanceCovers recent advances in the identification and function of small molecule inhibitors that target novel HIV-1 regulatory and s.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 144,18
Anzahl: 4 verfügbar
In den WarenkorbZustand: New. Print on Demand pp. 254.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND pp. 254.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 154,15
Anzahl: 4 verfügbar
In den WarenkorbZustand: New. Print on Demand pp. 254.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND pp. 254.
Sprache: Englisch
Verlag: Springer, Springer Mai 2015, 2015
ISBN 10: 3319185179 ISBN 13: 9783319185170
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 264 pp. Englisch.
Sprache: Englisch
Verlag: Springer, Springer Okt 2016, 2016
ISBN 10: 3319374508 ISBN 13: 9783319374505
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 264 pp. Englisch.